Ni Y - Search Results

1

Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load.

Schuch A, Salimi Alizei E, Heim K, Wieland D, Kiraithe MM, Kemming J, Llewellyn-Lacey S, Sogukpinar Ö, Ni Y, Urban S, Zimmermann P, Nassal M, Emmerich F, Price DA, Bengsch B, Luxenburger H, Neumann-Haefelin C, Hofmann M, Thimme R. Schuch A, et al. Among authors: ni y. Gut. 2019 May;68(5):905-915. doi: 10.1136/gutjnl-2018-316641. Epub 2019 Jan 8. Gut. 2019. PMID: 30622109 Free article.

2

An anti-viral peptide derived from the preS1 surface protein of hepatitis B virus.

Kim DH, Ni Y, Lee SH, Urban S, Han KH. Kim DH, et al. Among authors: ni y. BMB Rep. 2008 Sep 30;41(9):640-4. doi: 10.5483/bmbrep.2008.41.9.640. BMB Rep. 2008. PMID: 18823587 Free article.

3

Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.

Schulze A, Schieck A, Ni Y, Mier W, Urban S. Schulze A, et al. Among authors: ni y. J Virol. 2010 Feb;84(4):1989-2000. doi: 10.1128/JVI.01902-09. Epub 2009 Dec 9. J Virol. 2010. PMID: 20007265 Free PMC article.

4

The pre-s2 domain of the hepatitis B virus is dispensable for infectivity but serves a spacer function for L-protein-connected virus assembly.

Ni Y, Sonnabend J, Seitz S, Urban S. Ni Y, et al. J Virol. 2010 Apr;84(8):3879-88. doi: 10.1128/JVI.02528-09. Epub 2010 Feb 3. J Virol. 2010. PMID: 20130049 Free PMC article.

5

Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.

Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S. Nkongolo S, et al. Among authors: ni y. J Hepatol. 2014 Apr;60(4):723-31. doi: 10.1016/j.jhep.2013.11.022. Epub 2013 Dec 1. J Hepatol. 2014. PMID: 24295872

6

Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.

Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, Sültmann H, Urban S. Ni Y, et al. Gastroenterology. 2014 Apr;146(4):1070-83. doi: 10.1053/j.gastro.2013.12.024. Epub 2013 Dec 19. Gastroenterology. 2014. PMID: 24361467

7

Entry of hepatitis B and C viruses - recent progress and future impact.

Baumert TF, Meredith L, Ni Y, Felmlee DJ, McKeating JA, Urban S. Baumert TF, et al. Among authors: ni y. Curr Opin Virol. 2014 Feb;4:58-65. doi: 10.1016/j.coviro.2013.12.002. Epub 2014 Jan 14. Curr Opin Virol. 2014. PMID: 24418809 Review.

8

Hepatitis B Virus-Infected HepG2hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8+ T Cells In Vitro.

Hoh A, Heeg M, Ni Y, Schuch A, Binder B, Hennecke N, Blum HE, Nassal M, Protzer U, Hofmann M, Urban S, Thimme R. Hoh A, et al. Among authors: ni y. J Virol. 2015 Jul;89(14):7433-8. doi: 10.1128/JVI.00605-15. Epub 2015 May 13. J Virol. 2015. PMID: 25972537 Free PMC article.

9

Restrictive influence of SAMHD1 on Hepatitis B Virus life cycle.

Sommer AF, Rivière L, Qu B, Schott K, Riess M, Ni Y, Shepard C, Schnellbächer E, Finkernagel M, Himmelsbach K, Welzel K, Kettern N, Donnerhak C, Münk C, Flory E, Liese J, Kim B, Urban S, König R. Sommer AF, et al. Among authors: ni y. Sci Rep. 2016 May 27;6:26616. doi: 10.1038/srep26616. Sci Rep. 2016. PMID: 27229711 Free PMC article.

10

Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options.

Lempp FA, Ni Y, Urban S. Lempp FA, et al. Among authors: ni y. Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10):580-9. doi: 10.1038/nrgastro.2016.126. Epub 2016 Aug 18. Nat Rev Gastroenterol Hepatol. 2016. PMID: 27534692 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,924 results

Search Page